Ardent Health director granted 14,231 RSUs

Havdala Ellen reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Havdala Ellen reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. director Ellen Havdala reported receiving a grant of 14,231 shares of common stock in the form of restricted stock units. These units will vest in full on the first anniversary of April 1, 2026, as long as she continues serving the company through that date. After this grant, she holds 115,367 shares of common stock directly.

Insider Trade Summary

Grant/Award: 14,231 shares

Grant/Award 1 txn

Insider Havdala Ellen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,231	$0.00	$0.00

Holdings After Transaction: Common Stock — 115,367 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Key Figures

RSU grant size: 14,231 shares Post-transaction holdings: 115,367 shares Grant price per share: $0.0000 per share

3 metrics

RSU grant size 14,231 shares Restricted stock units granted to director on April 1, 2026

Post-transaction holdings 115,367 shares Common stock directly owned after the award

Grant price per share $0.0000 per share Reported transaction price for the RSU award

Key Terms

restricted stock units, vest in full, continued service

3 terms

restricted stock units financial

"Represents restricted stock units that vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"restricted stock units that vest in full on the first anniversary"

continued service financial

"subject to the Reporting Person's continued service with the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARDT director Ellen Havdala report?

Director Ellen Havdala reported receiving a grant of 14,231 shares of Ardent Health common stock as restricted stock units. These were awarded at no cash cost per share and increase her direct holdings to 115,367 shares following the transaction.

How many Ardent Health (ARDT) shares does Ellen Havdala hold after this Form 4?

Following the reported award, Ellen Havdala directly holds 115,367 shares of Ardent Health common stock. This total includes the newly granted 14,231 restricted stock units, which are subject to future vesting based on her continued service with the company.

What are the vesting terms of Ellen Havdala’s ARDT restricted stock units?

The 14,231 restricted stock units granted to Ellen Havdala vest in full on the first anniversary of April 1, 2026. Vesting is conditioned on her continued service with Ardent Health through that vesting date, aligning the award with ongoing board tenure.

Did Ellen Havdala buy or sell Ardent Health (ARDT) shares on the market?

The filing shows a grant classified as an acquisition under code A, not an open-market trade. Havdala received 14,231 restricted stock units as an award, at a reported price of $0.0000 per share, rather than buying or selling shares on an exchange.

Is Ellen Havdala’s ownership in Ardent Health direct or indirect?

The Form 4 indicates Ellen Havdala’s ownership is direct, marked with code D for the reported holdings. The transaction involves common stock held in her own name, rather than through a trust, partnership, or other indirect ownership vehicle.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:51 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Havdala Ellen

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		14,231(1)	A	$0	115,367	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)